Website logo

Program

download as PDF
08:45 AM - 09:00 AM 15min

  • 08:45 AM - 09:00 AM
    Opening remarks

    Philipp Steven

09:00 AM - 10:10 AM 1h 10min

Session 1

Daniel Wolff, Avik Shome

Progress in understanding ocular GVHD pathogenesis

  • 09:00 AM - 09:20 AM
    Role of NFkB in ocular GVHD

    Avik Shome

  • 09:20 AM - 09:40 AM
    Fibroblast-Immune Cell Cross Talk in oGVHD

    Ajay Sharma

  • 09:40 AM - 10:00 AM
    Immune dysregulation and tissue remodeling in ocular GVHD

    Yoko Ogawa

  • 10:00 AM - 10:10 AM
    Discussion

10:10 AM - 10:30 AM 20min

Coffee break

10:30 AM - 12:00 PM 1h 30min

Session 2

Yoko Ogawa, Sandeep Jain

Novel targets and therapies for ocular GVHD

  • 10:30 AM - 10:50 AM
    Window of opportunity

    Sandeep Jain

  • 10:50 AM - 11:10 AM
    Non-pharmacological therapies for ocular GVHD

    Margarita Calonge

  • 11:10 AM - 11:30 AM
    Drug-repurposing in ocular GVHD

    Murugesan Vanathi

  • 11:30 AM - 11:50 AM
    From Clinical Phenotype to transcriptional Targets: A Drug Discovery Platform applicable for oGVHD

    Christoph Ullmer

  • 11:50 AM - 12:00 PM
    Discussion

12:00 PM - 01:00 PM 1h

Group Photo & Lunch Break

01:00 PM - 01:45 PM 45min

Keynote

  • 01:00 PM - 01:05 PM
    Introduction

    Philipp Steven

  • 01:05 PM - 01:45 PM
    Targeting new treatments to specific organs

    Stepanie Lee

01:45 PM - 03:00 PM 1h 15min

Session 3

Stepanie Lee, Leonie Mengesha

Early detection and/or prophylaxis of ocular GVHD

  • 01:45 PM - 02:05 PM
    Diagnosing ocular GVHD earlier: Diagnostic Challenges and Opportunities

    Sarah Sunshine

  • 02:05 PM - 02:25 PM
    The BEACON study

    Leonie Mengesha

  • 02:25 PM - 02:45 PM
    Navigating the dilemma of systemic therapy for organ-specific GVHD

    Daniel Wolff

  • 02:45 PM - 03:00 PM
    Discussion

03:00 PM - 03:30 PM 30min

Coffee break

03:30 PM - 04:40 PM 1h 10min

Session 4

Tina Dietrich-Ntoukas, Bjoern Bachmann

Surgery, advanced management and prevention of complications of ocular GVHD

  • 03:30 PM - 03:50 PM
    To dos and not to dos in catastrophic ocular GVHD

    Tina Dietrich-Ntoukas

  • 03:50 PM - 04:10 PM
    Scleral lenses in ocular GVHD

    Philip Keye

  • 04:10 PM - 04:30 PM
    Specialized-care program in ocular GVHD

    Tarik Isik

  • 04:30 PM - 04:40 PM
    Discussion

04:40 PM - 05:15 PM 35min

ePoster Session

Philipp Steven

  • 04:40 PM - 04:50 PM
    Adjunct Therapy with Topical Recombinant Deoxyribonuclease (DNase) in Dry Eye Disease

    Sridevi Nair

  • 04:50 PM - 05:00 PM
    Selecting between autologous serum, punctual cautery, and dacryocystectomy in severe ocular GVHD: Clinical outcomes and decision-making criteria

    Prajakta Dandekar

  • 05:00 PM - 05:10 PM
    Metabolic Alterations in Murine Skin Following induced Graft-versus-Host Disease

    Arghavan Lotfi

  • 05:10 PM - 05:15 PM
    Discussion

Looks like there are no sessions today for the selected program.
09:00 AM - 09:15 AM 15min

  • 09:00 AM - 09:15 AM
    Opening remarks

    Christof Scheid

09:15 AM - 10:00 AM 45min

Whitepaper & Roadmap

  • 09:15 AM - 09:20 AM
    Introduction

    Philipp Steven

  • 09:20 AM - 10:00 AM
    Discussion

10:00 AM - 11:30 AM 1h 30min

Session 5

Robert Zeiser, Michael E. Stern

Interplay between systemic and organ-specific GVHD

  • 10:00 AM - 10:20 AM
    Manifestations of systemic immunity in the eye

    Michael E. Stern

  • 10:20 AM - 10:40 AM
    Role of monocytes in innate immunity of the ocular surface

    Steven Pflugfelder

  • 10:40 AM - 11:00 AM
    Current understanding of the impact of intestinal microbiome on HSCT alloreactive phenomena and outcome

    Daniela Weber

  • 11:00 AM - 11:20 AM
    Cell death, inflammation and disease

    Hamid Kashkar

  • 11:20 AM - 11:30 AM
    Discussion

11:30 AM - 11:45 AM 15min

Coffee break

11:45 AM - 01:15 PM 1h 30min

Session 6

Jana Naetlitz, Thomas Krieg

Skin GVHD

  • 11:45 AM - 12:05 PM
    Pathophysiology of fibrotic remodeling in cutaneous cGvHD

    Jörg Distler

  • 12:05 PM - 12:25 PM
    Under the skin: the pathophysiology of cutaneous graft-versus-host disease

    Johanna Strobl

  • 12:25 PM - 12:45 PM
    Bicentric data of dermatological care for GvHD patients

    Suzan Al-Gburi

  • 12:45 PM - 01:05 PM
    Metabolic kinetics in cutaneous GvHD development

    Jana Naetlitz

  • 01:05 PM - 01:15 PM
    Discussion

01:15 PM - 02:15 PM 1h

Lunch break

02:15 PM - 03:30 PM 1h 15min

Session 7

Philipp Steven, Florian Kron

Orphan drug approvals and the patient perspective

  • 02:15 PM - 02:35 PM
    The ocular GVHD patient

    Patient representative

  • 02:35 PM - 02:55 PM
    eGVHD App and novel developments

    Helene Schoemans

  • 02:55 PM - 03:15 PM
    Health economics in GVHD

    Florian Kron

  • 03:15 PM - 03:30 PM
    Discussion

03:30 PM - 04:00 PM 30min

Coffee break

04:00 PM - 05:30 PM 1h 30min

Session 8

Christof Scheid, Paul Broeckelmann

Ocular toxicities beyond GVHD – Bispecifics, check-point inhibitors, ADCs and CAR-T

  • 04:00 PM - 04:20 PM
    iTox - Checkpoint inhibitors

    Paul Broeckelmann

  • 04:20 PM - 04:40 PM
    Antibody Drug-Conjugates

    Johannes Waldschmidt

  • 04:40 PM - 05:00 PM
    Bispecifics

    Christof Scheid

  • 05:00 PM - 05:20 PM
    CAR-T

    Christof Scheid

  • 05:20 PM - 05:30 PM
    Discussion

05:30 PM - 06:15 PM 45min

Wrap up

  • 05:30 PM - 06:00 PM
    What’s new, what have we learned?

    Chairs

  • 06:00 PM - 06:15 PM
    Farewell comments

    Philipp Steven, Christof Scheid

Looks like there are no sessions today for the selected program.

Day 1

03/19/2026

Day 2

03/20/2026